The recently established London Advanced Therapies (LAT) brings together the London scientific community working in the field of cell and gene-based therapies.

Funded by Research England, and led by King’s, Imperial College London and University College London, LAT aims to catalyse London’s capabilities and outputs in the area of Advanced Therapies, through fostering collaborative work, facilitating commercial partnerships and creating a microclimate for innovation.

We aim at positioning London, and the UK, as a global leader in Advanced Therapies commercialisation, with sustainability embedded through the breadth of commercial partnerships

Our Delivery Leads:

Professor Adrian Thrasher, Professor in Paediatric Immunology and Wellcome Trust SRF, ICH Infect, Imm, Infla. & Physio Med, UCL GOS Institute of Child Health.

Professor Thomas Voit, Director of NIHR GOSH UCL Biomedical Research CentreI, CH Developmental Neurosciences Programme, UCL GOS Institute of Child Health.

Professor Uta Griesenbach, Professor of Molecular Medicine, Faculty of Medicine, National Heart & Lung Institute – Imperial College

Professor Eric Alton, Chair in Gene Therapy, Faculty of Medicine, National Heart & Lung Institute – Imperial College

Professor Alberto Sanchez Fueyo, Professor of Hepatology, Department of Inflammation Biology, Faculty of Life Sciences and Medicine

Professor Simon Howell, Director of Academic Estates Strategy for Health Campuses and Guy’s Campus Dean